Filter by
Publications (2019)
RSSSCCS Opinion on Triphenyl phosphate (CAS No. 204-112-2, EC No. 115-86-6)
Assessment of the supply chain vulnerabilities for the first tranche of the Union list of critical medicines: Technical report
Factsheet - Cross-border Healthcare in 2022
SCCS Opinion on on the safety of Silver (CAS/EC No. 7440-22-4/231-131-3) used in cosmetic products
Summary of the 2023 (2022 data) annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2023 (2022 data) annual reporting of serious adverse reactions and events for tissues and cells
Study supporting the report on trends in the falsification of medicinal products and measures provided according to Directive 2011/62/EU
SCHEER - UPDATE of the GUIDELINES on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
Guidance on outcomes for joint clinical assessments
Guidance on reporting requirements for multiplicity issues and subgroup, sensitivity and post hoc analyses in joint clinical assessments